stars 1 stars 2 stars 3

numares is a fast-growing innovative diagnostics company that develops and markets software-based test systems for high throughput use in clinical diagnostics and life science research. The AXINON® System and its individual diagnostic tests employ nuclear magnetic resonance (NMR) spectroscopy creating a “numaric” spectrum to evaluate metabolic networks. The output from these analyses provides physicians valuable information on the disease status of patients. numares developed its proprietary Magnetic Group Signaling (MGS®) technology to enable NMR for highly standardized and rapid throughput testing, forming a cost-effective new solution for real-time diagnostic purposes. The metabolic tests have the potential to address unmet medical needs in various field such as cardiovascular diseases, nephrology, oncology and neurology, shaping an important pillar in precision medicine. More information can be found at www.numares.com. For further information please contact: numares AG Dipl.-Biol. Christiane Proll, MBA Tel.: +49 941 2809 49-14 E-Mail: christiane.proll@numares.com

numares AG Questions

The numares AG annual revenue was $6.8 million in 2026.

Florian Voss is the CEO of numares AG.

19 people are employed at numares AG.

numares AG is based in Boston, Massachusetts.

The NAICS codes for numares AG are [62, 621].

The SIC codes for numares AG are [807, 80].

Top numares AG Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users